New combo attack on liver tumors shows promise
NCT ID NCT06311851
Summary
This study is testing a new combination treatment for cancer that has spread to the liver. It combines a standard procedure (TACE) that delivers chemotherapy directly to the liver tumor with an added drug (bevacizumab) that aims to starve the tumor by blocking its blood supply. The goal is to see if this combination is safe and effective at controlling the disease and helping patients live longer. The study is recruiting 40 adults with liver metastases who are not candidates for surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pardis Noor Medical Imaging and Cancer Center
RECRUITINGTehran, Tehran Province, 021, Iran
Contact
Conditions
Explore the condition pages connected to this study.